Sirona Biochem Corp Stock Fundamentals

SBM Stock  CAD 0.07  0.01  13.33%   
Sirona Biochem Corp fundamentals help investors to digest information that contributes to Sirona Biochem's financial success or failures. It also enables traders to predict the movement of Sirona Stock. The fundamental analysis module provides a way to measure Sirona Biochem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sirona Biochem stock.
At this time, Sirona Biochem's Interest Expense is fairly stable compared to the past year. Gross Profit is likely to climb to about 220.5 K in 2024, whereas Total Revenue is likely to drop slightly above 38 K in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sirona Biochem Corp Company Return On Equity Analysis

Sirona Biochem's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Sirona Biochem Return On Equity

    
  -98.1  
Most of Sirona Biochem's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sirona Biochem Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Sirona Total Stockholder Equity

Total Stockholder Equity

(2.15 Million)

Sirona Biochem reported Total Stockholder Equity of (2.26 Million) in 2023
Based on the latest financial disclosure, Sirona Biochem Corp has a Return On Equity of -98.1047. This is 309.28% higher than that of the Biotechnology sector and 169.07% higher than that of the Health Care industry. The return on equity for all Canada stocks is notably higher than that of the company.

Sirona Biochem Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sirona Biochem's current stock value. Our valuation model uses many indicators to compare Sirona Biochem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sirona Biochem competition to find correlations between indicators driving Sirona Biochem's intrinsic value. More Info.
Sirona Biochem Corp is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sirona Biochem's earnings, one of the primary drivers of an investment's value.

Sirona Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sirona Biochem's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sirona Biochem could also be used in its relative valuation, which is a method of valuing Sirona Biochem by comparing valuation metrics of similar companies.
Sirona Biochem is currently under evaluation in return on equity category among its peers.

Sirona Fundamentals

About Sirona Biochem Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sirona Biochem Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sirona Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sirona Biochem Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue40 K38 K
Cost Of Revenue65.4 K34.2 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Sirona Stock Analysis

When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.